|4Mar 3, 8:32 PM ET

GRAHAM RICHARD A 4

4 · Theravance Biopharma, Inc. · Filed Mar 3, 2023

Insider Transaction Report

Form 4
Period: 2023-03-01
GRAHAM RICHARD A
SVP, Development
Transactions
  • Award

    Ordinary Shares

    2023-03-01+75,000376,463 total

Documents

1 file
  • 4
    form4-03042023_010324.xmlPrimary